Related Experiment Video
Updated: Oct 11, 2025
03:23
Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
Published on: May 10, 2024
982
2021 year in review: Spotlight on eosinophils
Julia L M Dunn1, Marc E Rothenberg1
1Division of Allergy and Immunology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio.
The Journal of Allergy and Clinical Immunology
|November 28, 2021
Summary
Recent research reveals new insights into eosinophil biology and eosinophilic diseases, particularly in the gastrointestinal tract. Advanced technologies are uncovering complex roles of eosinophils, paving the way for novel therapeutic targets.
Area of Science:
- Immunology
- Gastroenterology
- Allergy
Background:
- Eosinophilic diseases are increasing, necessitating a deeper understanding of eosinophil function.
- Eosinophils play complex roles in tissue inflammation and immune modulation.
Purpose of the Study:
- To review recent advances in eosinophil biology and eosinophilic diseases.
- To highlight the impact of new technologies on understanding these conditions.
- To discuss the implications for future therapeutic strategies.
Main Methods:
- Next-generation sequencing
- Proteomic analysis
- Machine learning applied to tissue biopsies
- Analysis of clinical studies using monoclonal antibodies (mAbs)
Main Results:
- New technologies have elucidated mechanisms of eosinophilic inflammation and identified patient endotypes.
- Distinct eosinophil activation states in different tissues and diseases have been identified.
- Eosinophils exhibit both pro- and anti-inflammatory roles in allergic diseases.
Conclusions:
- A new paradigm of tissue-resident eosinophils with immunomodulatory functions is emerging.
- Understanding unique eosinophil activation states is key to developing novel therapies.
- Advances offer potential for targeted treatments for eosinophilic gastrointestinal diseases.
Related Concept Videos
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
675
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
675
01:26Asthma-II: Pathophysiology and Classification
3.3K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.3K
01:20Asthma: Pathogenesis and Management
815
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
815
01:14Erythropoiesis
5.0K
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
5.0K
01:30Asthma-IV: Diagnostic and Management
2.7K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.7K
01:33Enzyme-Linked Immunosorbent Assay
14.9K
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or...
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or...
14.9K